USPTO issues patent on Neurolixis Parkinson’s disease drug candidate

USPTO issues patent on Neurolixis Parkinson’s disease drug candidate
Feb. 4, 2020 / PRZen / WILMINGTON, Del. -- The United States Patent and Trademark Office (USPTO) has issued a patent on NLX-112, a drug candidate developed by Neurolixis for treatment of human ... read more
Source: Bing NewsPublished on 2020-02-04